PLDD With or Without Transforaminal Epidural Steroid Injection in Lumbar Disc Herniation

Condition(s) studied

Investigational drug(s) / intervention(s)

Percutaneous Laser Disc Decompression (PLDD): Routine minimally invasive laser-based disc decompression performed under fluoroscopic guidance to reduce intradiscal pressure in patients with lumbar disc herniation.

Transforaminal Anterior Epidural Steroid Injection: Routine transforaminal anterior epidural injection of dexamethasone performed under fluoroscopic guidance following PLDD during the same session without additional puncture.

Study summary

This prospective observational study aims to evaluate the clinical outcomes of patients with single-level lumbar disc herniation who undergo routine percutaneous laser disc decompression (PLDD).

In routine clinical practice, some patients receive an additional transforaminal anterior epidural steroid injection during the same session without an extra puncture. This study will prospectively follow patients who receive PLDD alone and those who receive PLDD combined with epidural steroid injection.

Pain intensity, functional status, analgesic use, need for additional interventions, and complications will be assessed over time. The results may help to clarify whether adding epidural steroid injection to PLDD improves clinical outcomes in patients with lumbar disc herniation.

Eligibility

Primary outcome measure(s)

• Change in Leg Pain Intensity (NRS) — Baseline to 1 month after procedure
  Change in leg pain intensity assessed using the Numeric Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates worst possible pain.

Trial sites (1)

More Mersin University trials in Turkey

Other trials for the same condition